Drug Type CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism CCL21 modulators(C-C motif chemokine ligand 21 modulators), IL-7 modulators(interleukin 7 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | China | 01 Nov 2022 |